Technology & AI Learning Specialist

Justyna Wilczynska-Baraniak joins Greenberg Traurig as Shareholder. Tools. Typography. Justyna Wilczynska-Baraniak has joined Greenberg Traurig as a Shareholder to establish the Tech, Cyber, IP, and Data Practice. Wilczynska-Baraniak joined together with a team of six lawyers. Before joining Greenberg Traurig, Wilczynska-Baraniak worked for EY as a Partner from 2018 to 2026. Before that, she worked for DLA Piper as a Senior Associate from 2011 to 2015 and as a Counsel from 2015 to 2018. Earlier, she worked for SK&S as an Attorney at Law from 2004 to 2011 and for Weil as an Associate from 2003 to 2004. "The creation of the Tech, Cyber, IP, and Data Practice is a deliberate response to where our clients' most pressing legal needs are heading," said Managing Partner Jolanta Nowakowska-Zimoch. "Cybersecurity, IP, AI, and data protection are no longer adjacent to the core business of our clients. They are at the heart of it. Justyna's arrival lets us bolster these competencies to meet the heightened expectations of our clients at the level of a top-tier international firm." "We are delighted to welcome Justyna Wilczynska-Baraniak and her team to Greenberg Traurig," added Senior Partner Lejb Fogelman. "Her expertise, market standing, and ability to build and lead a dedicated practice in these critical technology and regulatory areas will be of significant value to our clients and to the firm."

Global law firm Greenberg Traurig has added Phillip Aurentz as a shareholder in its Dallas office, expanding its Litigation and Intellectual Property & Technology practices. Aurentz joins from Sidley Austin. Aurentz is a first-chair trial lawyer specialising in complex, high-value litigation across state and federal courts. He has tried numerous cases to verdict, primarily involving patent disputes worth millions of dollars. His practice spans computing, oilfield services, heavy equipment, medical devices and banking sectors. A significant portion of his work focuses on intellectual property litigation, including patents and trade secrets, with nearly two decades of experience in Texas districts. Prior to law, he worked as a production gas plants project engineer. The addition continues Greenberg Traurig's growth strategy in Texas, following the recent hire of Beverly G. Oliver.

Greenberg Traurig adds shareholder Beverly Oliver to Health Care & FDA Practice in Dallas office. Apr 02, 2026, 16:00 ET DALLAS, April 2, 2026 /PRNewswire/ - Global law firm Greenberg Traurig, LLP strengthens its Health Care & FDA Practice with the addition of Beverly Oliver as a shareholder in its Dallas office. She joins the firm from SightGrowth Partners, where she served as chief legal officer and general counsel. Oliver represents private equity funds and private equity-backed health care portfolio companies, health systems, and medical practices across multiple states, handling complex transactions, joint ventures, and integration matters. She counsels clients on health care regulatory compliance, including issues involving CPOM prohibitions, HIPAA, Stark Law, the Anti-Kickback Statute, and the False Claims Act, and has handled government inquiries and settlement negotiations with federal agencies. Oliver assists health care companies with corporate and transactional structuring, diligence processes, and post-acquisition integration, and develops compliance programs and policies for health care organizations. "Beverly is a trusted adviser with deep experience working within the health care sector, spearheading legal transformation in high-growth environments. Her ability to guide organizations through complex change while delivering sound, forward-thinking counsel is what makes her such a powerful and effective strategic change agent," said Richard A. Rosenbaum, Greenberg Traurig's Executive Chairman. "Beverly's business-oriented perspective and extensive in-house counsel background add tremendous value to our growing team in Texas and to our dynamic Health Care & FDA Practice. Her arrival reflects our continued commitment to bringing world-class talent to bear for clients in Texas, where we have been for more than 20 years, across the country, and around the globe." Oliver's practice encompasses the full intersection of health care transactional and regulatory work, with a focus on supporting private equity-backed entities and health systems through complex mergers and acquisitions, integration, and compliance matters. "Beverly understands health care not just as a legal discipline, but as an industry. She knows how it operates, how it is regulated, and what is truly at stake when transactions close and the real work begins, which is a true asset for clients," said Lawson S. Parker, co-chair of the firm's Health Care & FDA Practice. "Beverly will bring her experience in regulatory structuring, diligence, and post-closing operational compliance directly to our private equity and other health care clients, and she is uniquely positioned to do so, having lived those challenges from the client's chair." As general counsel for health care companies, Oliver has overseen legal, compliance, and audit functions, managed legal teams, and worked closely with boards of directors, executive leadership, and private equity sponsors. Her in-house background includes experience with corporate integrity agreements, non-prosecution agreements, self-disclosures, health care regulatory investigations, contract negotiations, physician agreements, and health care system partnerships. "What stood out about Beverly was her vast experience across the full spectrum of health care law - from private practice to her in-house roles," said Joseph F. Coniglio, co-regional operating shareholder of Texas and managing shareholder of the firm's Dallas office. "She has an invaluable perspective, having handled numerous significant matters from both the client and counsel side of the table. That kind of dual vantage point sharpens a lawyer in ways that are immediately felt by the clients they serve." "Health care executives and operators are facing real pressures every day, and they need an adviser who has lived that experience, someone who understands not just the legal framework, but what it actually takes to run a health care organization," Oliver said. "Greenberg Traurig's global platform and the depth of its health care practice will allow me to support those clients, while building a practice that is truly my own. I look forward to working on various matters with clients at every stage." Beyond her legal practice, Beverly is deeply committed to her community, volunteering with the Dallas Volunteer Attorney Program to provide legal services to those in need and serving as an active member of the American Health Law Association, where she remains engaged in the broader dialogue shaping the future of health law. She also lends her time and energy to Girls on the Run and has completed the MS 150 Cycling Ride on multiple occasions. Greenberg Traurig's Health Care & FDA Practice is nationally recognized for representing a broad range of health care providers, investors, and industry participants in regulatory, transactional, and compliance matters. About Greenberg Traurig: Greenberg Traurig, LLP has approximately 3,100 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm's broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI "Best of the Best Recommended Law Firm" by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com. SOURCE Greenberg Traurig, LLP